SELCH LARSEN CLAUS has a total of 12 patent applications. Its first patent ever was published in 1988. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are CARDIOXYL PHARMACEUTICALS INC, HANGZHOU ADAMERCK PHARMLABS INC and ARIXA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 3 | |
#4 | Denmark | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Polysaccharides | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Larsen Claus Selch | 10 |
#2 | Larsen Susan Weng | 9 |
#3 | Kristensen Jesper Langgaard | 9 |
#4 | Thing Mette Agergaard | 9 |
#5 | Jensen Henrik | 9 |
#6 | Østergaard Jesper | 7 |
#7 | Olesen Henning Peter | 2 |
#8 | Harboe Elin | 2 |
#9 | Johansen Marianne | 2 |
#10 | Kurtzhals Peter | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016066612A1 | Imidazole derivatives as prodrugs of diclofenac | |
EP2991682A1 | Prodrugs of naproxen and diclofenac | |
US2014315960A1 | Prodrugs of non-steroid anti-inflammatory agents (NSAIDS) | |
DK110188D0 | High molecular weight prodrug derivatives of anti-flammatory drugs |